CYCN: Cyclerion Narx-foyda va o‘sish multiplikatori

Cyclerion (CYCN) kompaniyasining korporativ logotipi

Operatsion strukturaviy transformatsiyalar allaqachon narxga kiritilgan, shuning uchun PEG koeffitsiyenti dinamikasi joriy o'sishni ko'rsatmayapti. 0.00 ning joriy darajasi P/E ning o'sish nisbatini aks ettirib, aktivning qadrsizlanganini aniqlashga yordam beradi. Cyclerion Therapeutics (CYCN) biznes salohiyati pralinokain va sGC patentlarining rivojlanishiga tayanadi, nodir vaskulyar patologiyalar bo'yicha tadqiqotlarning diversifikatsiyasi esa kompaniyaning ilmiy risklarini minimallashtiradi.

Cyclerion Therapeutics - CYCN PEG multiplikatori (davr: 04.07.2022 - 09.09.2026)

Cyclerion (CYCN) kompaniyasining tahliliy kesimlari

Kompaniyaning fundamental tahlili:CYCN - Cyclerion Therapeutics
Cyclerion Therapeutics Inc. tayyor mahsulotlari

Uzoq muddatli xatarlarni minimallashtirish uchun investorlar P/E koeffitsiyentini foyda dinamikasi bilan solishtirgan holda o'sish xarajatlarini baholashlari lozim. Cyclerion Therapeutics (CYCN) narxlarni belgilash imkoniyatiga ega emas va kelgusidagi litsenziyalash to'lovlariga bog'liq bo'lganligi sababli, kompaniyaning baholanishi va uning o'sish sur'ati nisbati bo'yicha tahlil, fundamental barqarorligi gipotetik holatda qolgan tadqiqot tashkilotining salohiyati uchun bozor haddan tashqari ko'p to'layotganini aniqlashga yordam beradi.

Cyclerion Therapeutics raqobatchilari

O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Biogen Idec|Neurocrine Corp - Narx-foyda va o‘sish multiplikatori|regencellbioscience.com (RGC) - O‘sish sur’atiga tuzatilgan narx-foyda|AXSM - Narxning foydaga va o‘sish sur’atiga nisbati|ACAD (ACADIA Pharmaceuticals Inc.) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Xenon Pharmaceuticals (XENE) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti VKTX|Narxning foydaga va o‘sish sur’atiga nisbati Supernus|O‘sish sur’atiga tuzatilgan narx-foyda catalystpharma.com CPRX|Narx-foyda va o‘sish multiplikatori DNLI (Denali Therapeutics Inc.)|HRMY - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Biohaven Ltd. BHVN|AMLX (Amylyx) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Trevi Therapeutics Inc - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti PRAX (Praxis Precision Medicines)|AVXL: PEG multiplikatori|CBLL - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati prothena.com|Narx-foyda va o‘sish multiplikatori Alector (ALEC)|Narx-foyda va o‘sish multiplikatori ANNX (annexonbio.com)|OMER - O‘sish sur’atiga tuzatilgan narx-foyda|PEG multiplikatori NGNE (Neurogene Inc)|PEG multiplikatori AC Immune S.A. ACIU|VYGR - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati NMRA|SCLX (Scilex Holding Company) - Narx-foyda va o‘sish multiplikatori|TVGN (Tevogen Bio Holdings) - Narxning foydaga va o‘sish sur’atiga nisbati|ACOG (Alpha Cognition Corp) - PEG multiplikatori|Cognition Therapeutics, Inc. - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori IKT|SAVA (Cassava) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Assertio Holdings, Inc. - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti COYA|VistaGen Therapeutics, Inc. - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Ovid Therapeutics OVID|ABOS: PEG multiplikatori|CervoMed Corporation (CRVO) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Alterity Therapeutics Limited|Narxning foydaga va o‘sish sur’atiga nisbati CLNN|PEG multiplikatori PEPG|JUNS (Jupiter Neurosciences) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Relmada Corp RLMD|PEG multiplikatori Annovis Bio Corporation ANVS|gracetx.com - PEG multiplikatori|Firefly Neuroscience, Inc (AIFF) - Narx-foyda va o‘sish multiplikatori|Klotho Neurosciences (KLTO) - Narxning foydaga va o‘sish sur’atiga nisbati|NeuroSense Therapeutics, Ltd. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|RVPH (Reviva Pharmaceuticals Holdings) - PEG multiplikatori|MetaVia Inc (MTVA) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori NRXS|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Helius Medical Technologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati passagebio.com PASG|NEUP: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|NERV - Narxning foydaga va o‘sish sur’atiga nisbati|Athira - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|ADXN: PEG multiplikatori|ALZN (Alzamend Neuro, Inc.) - Narxning foydaga va o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati protagenic.com|Pasithea Therapeutics - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori CRGT (Cortigent, Inc.)|Avenue Therapeutics - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Brainstorm Cell BCLI|PEG multiplikatori caratherapeutics.com CARA|Chromocell Therapeutics Corp. - PEG multiplikatori|eliemtx.com - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Intra-Cellular Therapies (ITCI) - Narxning foydaga va o‘sish sur’atiga nisbati|LBPH (Longboard) - Narxning foydaga va o‘sish sur’atiga nisbati|MRNS (marinuspharma.com) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda NKGen Biotech NKGN|Narxning foydaga va o‘sish sur’atiga nisbati NeuroBo Pharma (NRBO)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati SAGE|Synaptogenix, Inc. - Narx-foyda va o‘sish multiplikatori|TRVN: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|VIGL - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti WENA (Anew Medical, Inc.)|CERE: PEG multiplikatori